3
Soon, the Economic Partnership Agreement (EPA) between Japan and the EU will come into force. Along with an already signed Memoran- dum of Cooperation in Health by the Japanese and Danish Ministers of Health, followed by the fruitful Royal visit to Japan in 2017, there is a unique opportunity for Danish companies to explore and exploit trade and cooperation with- in the Japanese Health sector. The Confederation of Danish Industry and the Embassy of Denmark in Japan invite you to re- visit the Japanese healthcare sector with a dele- gation to gain knowledge of and build trade re- lations to the Japanese health sector. MARKET FACTS Japan has become the second largest market for pharmaceuticals, taking up 11,7 per cent of the global market and imports exceed DKK 5,000 m. The new trade agreement opens up for opportuni- ties attractive to Danish companies who whishes to enter the Japanese market. From the EPA, three things should be emphasised: The agreement will increase Danish export to Japan with up to 70 per cent. (Copenhagen Economics) The agreement has a strong focus on SMEs, easing the process of entering the market. Japan has increased its focus on easing the barriers of imported products in the healthcare sector. The EPA will allow for more European companies to bid on public procurements in Japan at the same level as the Japanese companies. Public procure- ment of private products and services amounts to 13 per cent of Japans GDP. This will give Danish companies access to the possibilities in relation to Japans aging population and the countrys in- creased focus on the development of a sustainable and modern healthcare sector with better pharma- ceuticals and more welfare technology. Read more about the EPA here. Read more about the Memorandum of Coop- eration in Health between Denmark and Ja- pan here. WHY JOIN? The program will be tailored to the participating companies and their ambitions and challenges in the Japanese market. Because of the agreement between Japan and Denmark, the Danish embassy in Japan has improved access to Japanese healthcare authori- ties. You will get: Unique access to Japanese healthcare market Meetings with government stakeholders B2B with Japanese healthcare companies Visits to hospitals and nursing homes A GATEWAY TO THE JAPANESE HEALTHCARE MARKET 812 April 2019, Japan Registration deadline: 8 February 2019

A A AY A A A A A April 2019, apan · A A 8 April, onday • Arrival in Tokyo • Industry briefing at the Embassy • Informal welcome dinner (own ex- pense) 9 April, uesday • Visit

Embed Size (px)

Citation preview

Page 1: A A AY A A A A A April 2019, apan · A A 8 April, onday • Arrival in Tokyo • Industry briefing at the Embassy • Informal welcome dinner (own ex- pense) 9 April, uesday • Visit

Soon, the Economic Partnership Agreement (EPA) between Japan and the EU will come into force. Along with an already signed Memoran-dum of Cooperation in Health by the Japanese and Danish Ministers of Health, followed by the fruitful Royal visit to Japan in 2017, there is a unique opportunity for Danish companies to explore and exploit trade and cooperation with-in the Japanese Health sector. The Confederation of Danish Industry and the Embassy of Denmark in Japan invite you to re-visit the Japanese healthcare sector with a dele-gation to gain knowledge of and build trade re-lations to the Japanese health sector.

MARKET FACTS Japan has become the second largest market for

pharmaceuticals, taking up 11,7 per cent of the

global market and imports exceed DKK 5,000 m.

The new trade agreement opens up for opportuni-

ties attractive to Danish companies who whishes to

enter the Japanese market. From the EPA, three

things should be emphasised:

• The agreement will increase Danish export to Japan with up to 70 per cent. (Copenhagen Economics)

• The agreement has a strong focus on SMEs, easing the process of entering the market.

• Japan has increased its focus on easing the barriers of imported products in the healthcare sector.

The EPA will allow for more European companies to

bid on public procurements in Japan at the same

level as the Japanese companies. Public procure-

ment of private products and services amounts to

13 per cent of Japan’s GDP. This will give Danish

companies access to the possibilities in relation to

Japan’s aging population and the country’s in-

creased focus on the development of a sustainable

and modern healthcare sector with better pharma-

ceuticals and more welfare technology.

• Read more about the EPA here.

• Read more about the Memorandum of Coop-

eration in Health between Denmark and Ja-

pan here.

WHY JOIN?

The program will be tailored to the participating companies and their ambitions and challenges in the Japanese market. Because of the agreement between Japan and Denmark, the Danish embassy in Japan has improved access to Japanese healthcare authori-ties. You will get:

• Unique access to Japanese healthcare market

• Meetings with government stakeholders

• B2B with Japanese healthcare companies

• Visits to hospitals and nursing homes

A GATEWAY TO THE JAPANESE HEALTHCARE MARKET 8—12 April 2019, Japan Registration deadline: 8 February 2019

Page 2: A A AY A A A A A April 2019, apan · A A 8 April, onday • Arrival in Tokyo • Industry briefing at the Embassy • Informal welcome dinner (own ex- pense) 9 April, uesday • Visit

TENTATIVE PROGRAMME

8 April, Monday

• Arrival in Tokyo

• Industry briefing at the Embassy

• Informal welcome dinner (own ex-

pense)

9 April, Tuesday

• Visit to larger University Hospital

• Nursing home visit: See robotic solu-

tions implemented in care

• Networking reception

10 April, Wednesday

• Visit Japanese company

• Visit Danish company in Japan

• Meeting with Japanese “FDA”, the Phar-

maceutical and Medical Device Agency

on an update on regulatory discussions

• Train to Osaka

11 April, Thursday

• Visit Kobe life science cluster FBRI

• B2B with West Japanese companies

• Visit Osaka University Hospital

• Train to Tokyo

12 April, Friday

• Departure to Copenhagen

Read detailed programme here.

A GATEWAY TO THE JAPANESE HEALTHCARE MARKET 8—12 April 2019, Japan Registration deadline: 8 February 2019

WHO SHOULD JOIN?

This trade agreement - along with the healthcare

cooperation agreement between Japan and Den-

mark - creates a very fertile ground for Danish

companies to expand their businesses in the Japa-

nese healthcare market. Denmark is particularly

seen to have a competitive advantage within:

• Welfare technologies

• Telemedicine

• Doctor-to-doctor and doctor-to-patient tech-nologies

If you are in doubt about your company’s fit to this program or industry, please contact Nina Milling Riiser, the responsible advisor for this project. Contact information can be found on the next page.

Page 3: A A AY A A A A A April 2019, apan · A A 8 April, onday • Arrival in Tokyo • Industry briefing at the Embassy • Informal welcome dinner (own ex- pense) 9 April, uesday • Visit

PRACTICAL INFORMATION PRICE DKK 15,500 excluding VAT (one person per company)

HOTEL AND TRAVEL INFORMATION A voluntary traveling offer will be made available through BCD Travel.

SAVE TIME AND MONEY ON YOUR ATA CARNET DI’s Chamber of Commerce can help you and your company with an

ATA Carnet. As a member you get a 50 per cent discount. The ATA Car-

net is a document permitting temporary duty-free and tax-free export

and import of goods (up to one year). Using a carnet is the easiest way

to speed through customs and save money. Please contact

DI Certifikatservice (DI Chamber of Commerce), we are ready to help

you with your ATA Carnet and answer your questions, if any. Read more

here.

HOW TO REGISTER

Please register by clicking ‘REGISTER HERE’ to follow the link to the online registration form.

Deadline for binding registration is 8 February, 2019.

REGISTER HERE

A GATEWAY TO THE JAPANESE HEALTHCARE MARKET 8—12 April 2019, Japan Registration deadline: 8 February 2019

Nina Milling Riiser Advisor (+45) 3377 3672

(+45) 4072 8975 (mobile)

Royal Danish Embassy in Tokyo

Peter Takizawa

(+81) 3 3780 8718

[email protected]

CONTACT

THE FINE PRINT

The cost is calculated based on a minimum of 7 companies participating, subsidies from the Danish Trade Council is included.

If the subsidy from the Danish Trade Council is not obtained, and/or the number of par-ticipating companies alters, we reserve the right to offer you the basic package at differ-ent cost. Should this result in a cost increase, you have the right to cancel your participa-tion.

Travel expenses (to/from Japan), hotel ac-

commodation and other expenditure not

men-tioned above, are at your own expense.